Pharmacological inhibition of Rho-ROCK using either Fasudil or Y-27632 decreased the invasion, stress fiber organization and migration in pancreatic adenocarcinoma cells and breast cancer cells in vitro 159, suggesting a cell-autonomous role for Rho-ROCK signaling in tumor progression. This evidence concerns the gene RHO and breast carcinoma.